Office: U627
Tel:08-7624002 ext. 2627
E-mail: bear@tajen.edu.tw
Overall academic performance and ORCID information
To the current date, Dr. Yi-Hong Tsai has published 50 academic articles. According to ORCID data and Scopus preview, total citation of Dr. Yi-Hong Tsai was accumulated to 958 in 930 articles, the h-index is now 15 (https://orcid.org/0000-0003-4674-3363, Scopus Author ID: 54944623200, Records till 2025/01/04). Furthermore, Dr. Tsai obtained 16 filing or granted patents and 7 transferred technologies to be utilized in industry along with participating or conducting 30+ projects funded by TW government or industry-academia cooperation.
Current positions
- Assistant professor, Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, Taiwan.
- Director, Office of Institutional Research and Sustainable Development, Office of Secretariat, Tajen University, Taiwan.
Education
- Ph.D. in PharmSci, Graduate Institute of Natural Products, Kaohsiung Medical University.
Employments and experiences
- 2016-2023: Postdoctoral researcher, Graduate Institute of Natural Products, Kaohsiung Medical University, Taiwan.
- 2019: Research abroad fellow, Faculty of Pharmacy, University of Szeged, Hungary.
Experiences
- Pilot study of new botanic drugs, R&D on natural products and healthy foods.
- Supercritical fluid extraction, Instrumental analysis, Spectroscopy, Pharmaceutical analysis and pharmacognosy.
Association attended
-
2024 Academic Committee Members, The Society of Chinese Natural Medicine.
-
2023 Academic Committee Members, The Society of Chinese Natural Medicine.
-
The Society of Chinese Natural Medicine, Life Member.
-
The Pharmaceutical Society of Taiwan, Life Member.
Award
- Kaohsiung Medical University -9th Campus Innovation and Entrepreneurship Competition - Entrepreneurship Category - Third Place, EPIC FUNGI, 2020.
- The Society of Chinese Natural Medicine (SCNM) -Outstanding Academic Award in Natural Products – Young Scholar Award, the 37th Symposium on Natural Products & the Ceremony in Honor of Late Academician Professor Kuo-Hsiung Lee - Nature is the Best Guide, 2022.
- TJU - "Recruitment and Retention of Outstanding Talent" Flexible Allowance Incentive, 112-2.
- TJU - "Recruitment and Retention of Outstanding Talent" Flexible Allowance Incentive, 113-1.
- TJU - 2024 Academic Year Teacher Incentive Program for Practical Teaching: Award for Teachers Developing and Applying Teaching Materials.
- TJU - 2024 Academic Year Teacher Incentive Program for Promoting Practical Teaching.
- TJU - 2024 Campus Innovation and Creativity Practice Exemplary Award Competition - Excellence Award: Application of AI and SDGs Sustainability Concepts in Lesson Plan Design and Techniques to Enhance Administrative Efficiency (Office of Institutional Research and Sustainable Development Team).
- TJU - 2024 Campus Innovation and Creativity Practice Exemplary Award Competition - Excellence Award: Development of Unique Features and Resource Value-Added Activation in Higher Education Institutions (Office of Institutional Research and Sustainable Development Team).
- TJU - 2024 Campus Innovation and Creativity Practice Exemplary Award Competition - Merit Award: Program for Enhancing Leadership Consensus and Cross-Unit Collaboration Efficiency (Office of Institutional Research and Sustainable Development Team).
Journal reviewer
- Review Editor for Ethnopharmacology, Frontiers in Pharmacology (Impact factor = 4.40. Ranked Q1, Top 18.2% in PHARMACOLOGY & PHARMACY - SCIE).
- Reviewer, Phytomedicine. (Impact factor = 6.70. Ranked Q1, Top 3.5% in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).
Publications
- Wan-Hsuan Chang, Yu-Fan Chuang, Po-Chien Li, Hung-Te Hsu, Wei-Yu Fang, Szu-Yin Yu, Yi-Hong Tsai, Chih-Lung Lin, Fang-Rong Chang, Yi-Ching Lo, 2024. “Gan-Mai-Da-Zao-Tang attenuates age-induced skeletal muscle wasting and improves mitochondrial function in mice.” J. Tradit. Med. Complement., accepted, in press. (Impact factor = 3.3. Ranked Q1, Top 19.8% in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).
- Ya-Ting Chuang, Ching-Yu Yen, Jen-Yang Tang, Fang-Rong Chang, Yi-Hong Tsai, Kuo-Chuan Wu, Tsu-Ming Chien, Hsueh-Wei Chang, 2024. “The modulation of immune cell death in connection to microRNAs and natural products.” Front. Immunol. 15:1425602. (Impact factor = 5.7. Ranked Q1, Top 20.2% in IMMUNOLOGY - SCIE).
- Ya-Ting Chuang, Ching-Yu Yen, Tsu-Ming Chien, Fang-Rong Chang, Kuo-Chuan Wu, Yi-Hong Tsai, Jun-Ping Shiau, Hsueh-Wei Chang, 2024. “Natural products modulate phthalate-associated miRNAs and targets.” Ecotoxicol. Environ. Saf., 284:117015. (Impact factor = 6.2. Ranked Q1, Top 8.0% in TOXICOLOGY - SCIE).
- Ya-Ting Chuang, Ching-Yu Yen, Jen-Yang Tang, Kuo-Chuan Wu, Fang-Rong Chang, Yi-Hong Tsai, Tsu-Ming Chien, Hsueh-Wei Chang, 2024. “Marine anticancer drugs in modulating miRNAs and antioxidant signaling.” Chem. Biol. Interact., 25(399):111142. (Impact factor = 4.7. Ranked Q1, Top 15.4% in PHARMACOLOGY & PHARMACY - SCIE).
- Ya-Ting Chuang, Ching-Yu Yen, Tsu-Ming Chien, Fang-Rong Chang, Yi-Hong Tsai, Kuo-Chuan Wu, Jen-Yang Tang, Hsueh-Wei Chang, 2024. “Ferroptosis-Regulated Natural Products and miRNAs and Their Potential Targeting to Ferroptosis and Exosome Biogenesis.” Int. J. Mol. Sci., 25(11): 6083. (Impact factor = 4.9. Ranked Q1, Top 20.9% in BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE).
- Hao-Chun Hu, Szu-Yin Yu, Yi-Hong Tsai, Pei-Wen Hsieh, Hui-Chun Wang, Yan-Ning Chen, Ya-Ting Chuang, Min-Yu Lee, Hsueh-Wei Chang, Hao-Chun Hu, Yang-Chang Wu, Fang-Rong Chang, István Szatmári, Ferenc Fülöp, 2024. “Synthesis of bioactive evodiamine and rutaecarpine analogues under a ball milling condition.” Org. Biomol. Chem., 22, 2620-2629. (Impact factor = 2.9. Ranked Q1, Top 21.6% in CHEMISTRY, ORGANIC - SCIE).
- Yi-Hong Tsai1, Yen Chi Loo1, Hsieh Chen, Hui-Ping Hsieh, Yen-Chang Chen, Hsueh-Er Chen, Zhi-Hu Lin, Tse-Hung Huang, I-Min Liu, Chia-Ching Liaw, Fang-Rong Chang, 2024. “Quality and production enhancement of fish mint, Houttuynia cordata Thunb., cultivated in a hydroponic planting system with designed plant growth-promoting additives.” Heliyon, 10(7):e28755. (Impact factor = 3.4. Ranked Q1, Top 20.5% in MULTIDISCIPLINARY SCIENCES - SCIE). First author.
- Ya-Ting Chuang, Ching-Yu Yen, Jen-Yang Tang, Fang-Rong Chang, Yi-Hong Tsai, Kuo-Chuan Wu, Tsu-Ming Chien, Hsueh-Wei Chang, 2024. “Protein phosphatase 2A modulation and connection with miRNAs and natural products.” Environ. Toxicol, 39(6):3612-3627. (Impact factor = 4.4. Ranked Q1 in TOXICOLOGY - SCIE).
- Ya-Ting Chuang, Ching-Yu Yen, Jun-Ping Shiau, Fang-Rong Chang, Chang-Yih Duh, Ping-Jyun Sung, Kuan-Liang Chen, Yi-Hong Tsai, Jen-Yang Tang, Jiiang-Huei Jeng, Jyh-Horng Sheu, Hsueh-Wei Chang, 2024. “Demethoxymurrapanine, an indole-naphthoquinone alkaloid, inhibits the proliferation of oral cancer cells without major side effects on normal cells.” Environ. Toxicol., 39(3), 1221–1234. (Impact factor = 4.4. Ranked Q1, Top 18% in TOXICOLOGY - SCIE).
- Jen-Yang Tang, Ya-Ting Chuang, Jun-Ping Shiau, Ching-Yu Yen, Fang-Rong Chang, Yi-Hong Tsai, Ammad Ahmad Farooqi, Hsueh-Wei Chang, 2023. “Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis.” Int. J. Mol. Sci., 24(15):12449. (Impact factor = 6.208. Ranked Q1, Top 23% in BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE).
- Ya-Ting Chuang, Jun-Ping Shiau, Jen-Yang Tang, Ammad Ahmad Farooqi, Fang-Rong Chang, Yi-Hong Tsai, Ching-Yu Yen, Hsueh-Wei Chang*, 2023. “Connection of Cancer Exosomal LncRNAs, Sponging miRNAs, and Exosomal Processing and Their Potential Modulation by Natural Products.” Cancers, 15(8), 2215. (Impact factor = 6.675. Ranked Q1, Top 24.29% in ONCOLOGY - SCIE).
- Yen Chi Loo, Hao-Chun Hu, Szu-YinYu, Yi-Hong Tsai, Michal Korinek, Yang-ChangWu*, Fang-Rong Chang*, Ying-JungChen*, 2023. “Development on potential skin anti-aging agents of Cosmos caudatus Kunth via inhibition of collagenase, MMP-1 and MMP-3 activities.” Phytomedicine, 110:154643. (Impact factor = 6.655. Ranked Q1, No.1 in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).
- Wei-Yu Fang, Chih-Lung Lin, Wan-Hsuan Chang, Chih-Hsiang Chang, Yun-Cian Huang, Yi-Hong Tsai, Fang-Rong Chang, Yi-Ching Lo*, 2022. “Protective effects of a chalcone-based derivative AN07 on inflammation-associated myotube atrophy induced by lipopolysaccharide.” Int. J. Mol. Sci., accepted, Int. J. Mol. Sci., 23(21):12929. (Impact factor = 6.208. Ranked Q1, Top 23% in BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE).
- Wei-Yu Fang, Wan-Hsuan Chang, Yi-Hong Tsai, Hung-Te Hsu, Feng-Rong Chang, Chih-Lung Lin, Yi-Ching Lo*, 2022. “Guilu Erxian Jiao enhances protein synthesis, glucose homeostasis, mitochondrial biogenesis and slow-twitch fibers in the skeletal muscle.” J. Food Drug Anal., 31(1), Article 8. (Impact factor = 6.157. Ranked Q1, Top 16% in PHARMACOLOGY & PHARMACY - SCIE).
- Hao-Chun Hu, Szu-Yin Yu, Xiao-Shan Hung, Chun-Han Su, Yu-Liang Yang, Chien-Kei Wei, Yuan-Bin Cheng, Yang-Chang Wu, Chia-Hung Yen, Tsong-Long Hwang, Shu-Li Chen, István Szatmári, Attila Hunyadi, Yi-Hong Tsai*, Fang-Rong Chang*, 2022. “Composition decipherment of F. pumila var. awkeotsang and its potential on COVID-19 symptom amelioration and in silico prediction of SARS-CoV-2 interference.” J. Food Drug Anal., 30(3), Article 9. (Impact factor = 6.157. Ranked Q1, Top 16% in PHARMACOLOGY & PHARMACY - SCIE). Corresponding author.
- Michal Korinek, Heba Handoussa, Olha Mykhailenko, Meng-Hua Chen, Zan-Wei Chiou, You-Ying Chen, Yi-Hong Tsai, Bing-Hung Chen, Mohamed El-Shazly, Tsong-Long Hwang*, 2021. “Antimicrobial and anti-inflammatory effects of volatile oils widely used in Mediterranean diet.” Free Radic. Biol. Med., 165(1), 38. (Impact factor = 8.101. Ranked Q1, Top 9% in ENDOCRINOLOGY & METABOLISM).
- Wei-Kuang Lai, Yang-Chang Wu, Tai-Sheng Yeh, Chun-Ren Hsieh, Yi-Hong Tsai, Chien-Kei Wei, Chi-Ying Li, Ying-Chen Lu*, Fang-Rong Chang*, 2021. “The protoplast two-way fusions and fusant characteristics of Antrodia cinnamomea and Cordyceps militaris.” Food Sci. Hum. Wellness, 11(5), 1240-1251. (Impact factor = 8.022. Ranked Q1, Top 10% in NUTRITION & DIETETICS - SCIE).
- Abdel Nasser B Singab, Nada M Mostafa, Yasmin A Elkhawas, Eman Al-Sayed, Mokhtar M Bishr, Ahmed M Elissawy, Mohamed S Elnaggar, Iten M Fawzy, Osama M Salama, Yi-Hong Tsai, Fang-Rong Chang*, 2021. “Cyclodepsipeptides: isolation from endophytic fungi of Sarcophyton ehrenbergi and verification of their larvicidal activity via in-vitro and in-silico studies.” Mar. Drugs., 20(5), 331. (Impact factor = 6.085, ranked Q1, Top 16% in CHEMISTRY, MEDICINAL - SCIE).
- Yi-Hong Tsai, Fang-Rong Chang*, YangChang Wu*, 2022. “In memory of professor Kuo-Hsiung Lee (K. H. Lee).” J. Tradit. Complement. Med. 12(2), 217-218. (Impact factor = 4.221. Ranked Q2, top 27% in INTEGRATIVE & COMPLEMENTARY MEDICINE)). First author.
- Chi-Jung Tai, Mohamed El-Shazly, Yi-Hsin Yang, Yi-Hong Tsai, Dezső Csupor, Judit Hohmann, Yang-Chang Wu, Tzyy-Guey Tseng, Fang-Rong Chang*, Hui-Chun Wang*, 2022. “The effectiveness of Fuzi in combination with routine heart failure treatment on chronic heart failure patients” J. Ethnopharmacol., 289: 115040. (Impact factor = 5.195. Ranked Q1, Top 12.98% in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).
- Chiao-Chih Huang, Tzu-Ching Lin, Chiung-Hui Liu, Hao-Chun Hu, Szu-Yin Yu, Shu-Jing Wu, Ming-Hong Yen, Yi-Hong Tsai*, Fang-Rong Chang*, 2021. “Lipid metabolism and its mechanism triggered by supercritical CO2 extract of adlay (Coix lacryma-jobi var. ma-yuen (Rom. Caill.) Stapf) bran in high fat diet-induced hyperlipidemic hamsters.” Front. Pharmacol., 12:785944. (Impact factor = 5.988. Ranked Q1, Top 18% in PHARMACOLOGY & PHARMACY - SCIE). Corresponding author.
- Michal Korinek, Heba Handoussa, Yi-Hong Tsai, You-Ying Chen, Meng-Hua Chen, Zan-Wei Chiou, Yu Fang, Fang-Rong Chang, Chia-Hung Yen, Chung-Fan Hsieh, Bing-Hung Chen, Mohamed El-Shazly, Tsong-Long Hwang, 2021. “Anti-inflammatory and antimicrobial volatile oils: Fennel and cumin inhibit neutrophilic inflammation via regulating Calcium and MAPKs.” Front. Pharmacol., 12:674095. (Impact factor = 5.988. Ranked Q1, Top 18 in PHARMACOLOGY & PHARMACY - SCIE).
- Kartiko Arif Purnomo, Michal Korinek, Yi-Hong Tsai, Hao-Chun Hu, Yi-Hsuan Wang, Anders Backlund, Tsong-Long Hwang, Bing-Hung Chen, Shih-Wei Wang, Chin-Chung Wu, Fang-Rong Chang*, 2021. “Decoding multiple biofunctions of maca on its anti-allergic, anti-inflammatory, anti-thrombotic, and pro-angiogenic activities.” J. Agri. Food Chem., 69(40):11856-11866. (Impact factor = 5.895. Ranked Q1, Top 10% in AGRICULTURE, MULTIDISCIPLINARY - SCIE).
- Bernard S. Canusa, Ivan L. Lawag, Oliver B. Villaflores, Vitthal D. Wagh, Michal Korinek, Yi-Hong Tsai, Fang-Rong Chang, Ma. Alicia M. Aguinaldo*, 2021. “α-Glucosidase inhibitors from the bark extract of ethno-antidiabetic Ceriops tagal (Perr.) C.B. Rob” Philipp. J. Sci., 151 (S1): 25-60.
- Yi-Hong Tsai1, Hao-Chun Hu1, Yu-Che Chuang, Kuei-Hung Lai, Yu-Ming Hsu, Tsong-Long Hwang, Chih-Chan Lin, Ferenc Fülöp, Yang-Chang Wu, Szu-Yin Yu, Yu-Ting Kuo*, Fang-Rong Chang*, 2021. “Estrogenic and anti-neutrophilic inflammatory phenanthrenes from Juncus effusus L.” Nat. Prod. Res., 2021 Sep 9;1-11. (Impact factor = 2.861. Ranked Q2 in CHEMISTRY, APPLIED - SCIE). First author.
- Ching-Chia Chang, Chi-Ying Li, Yi-Hong Tsai, Mohamed El-Shazly, Chien-Kei Wei, Zih-Jie Yang, Shu-Li Chen, Chin-Chung Wu, Yang-Chang Wu, Fang-Rong Chang *, 2021. “Bioactive polyketides from the pathogenic fungus of Epicoccum sorghinum.” Planta, 253(6):116. (Impact factor = 4.540. Ranked Q1, Top 17% in PLANT SCIENCES - SCIE).
- Chi-Jung Tai, Mohamed El-Shazly, Yi-Hong Tsai, Dezső Csupor, Judit Hohmann, Yang-Chang Wu, Tzyy-Guey Tseng, Fang-Rong Chang*, Hui-Chun Wang*, 2021. “Uncovering modern clinical applications of Fuzi and Fuzi-based formulas: A nationwide descriptive study with market basket analysis.” Front. Pharmacol., 12:674095. (Impact factor = 5.988. Ranked Q1, Top 18 in PHARMACOLOGY & PHARMACY - SCIE).
- Tzu-Jung Yu, Yuan-Bin Cheng, Li-Ching Lin, Yi-Hong Tsai, Bo-Yi Yao, Jen-Yang Tang, Fang-Rong Chang, Chia-Hung Yen, Fu Ou-Yang, Hsueh-Wei Chang*, 2021. “Physalis peruviana-derived physapruin A (PHA) inhibits breast cancer cell proliferation and induces oxidative-stress-mediated apoptosis and DNA damage.” Antioxidants, 10(3):393. (Impact factor = 7.675. Ranked Q1, Top 6% in CHEMISTRY, MEDICINAL - SCIE).
- Wei-Kuang Lai, Ying-Chen Lu, Chun-Ren Hsieh, Chien-Kei Wei, Yi-Hong Tsai, Fang-Rong Chang*, You Chan*, 2021. “Developing lactic acid bacteria as an oral healthy food.” Life-Basel, 11(4): 268. (Impact factor = 3.251. Ranked Q2 in BIOLOGY - SCIE).
- Hao-Chun Hu, Chi-Ying Li, Yi-Hong Tsai, Dai-Yun Yang, Yang-Chang Wu, Tsong-Long Hwang, Shu-Li Chen, Ferenc Fülöp, Attila Hunyadi, Chia-Hung Yen, Yuan-Bin Cheng, Fang-Rong Chang*, 2020. “Secondary metabolites and bioactivities of Aspergillus ochraceopetaliformis isolated from Anthurium brownie.” ACS Omega, 5(33):20991-20999. (Impact factor = 4.132. Ranked Q2 in CHEMISTRY, MULTIDISCIPLINARY - SCIE).
- Chi-Ying Li, Ching-Chia Chang, Yi-Hong Tsai, Mohamed El-Shazly, Chin-Chung Wu, Shih-Wei Wang, Tsong-Long Hwang, Chien-Kei Wei, Judit Hohmann, Zih-Jie Yang, Yuan-Bin Cheng, Yang-Chang Wu, Fang-Rong Chang*, 2020. “Anti-inflammatory, antiplatelet aggregation, and antiangiogenesis polyketides from Epicoccum sorghinum: Toward an understating of its biological activities and potential applications.” ACS Omega, 5(19), 11092–11099. (Impact factor = 4.132. Ranked Q2 in CHEMISTRY, MULTIDISCIPLINARY - SCIE).
- Chih-Wen Chen, Chih-Fong Tsai, Yi-Hong Tsai, Yang-Chang Wu*, Fang-Rong Chang*, 2020. “Association rule mining for the ordered placement of traditional Chinese medicine containers: An experimental study.” Medicine, 99(18): e20090. (Impact factor = 1.817. Ranked Q3 in MEDICINE, GENERAL & INTERNAL – SCIE).
- Chih‐Wen Chen, Yi‐Hong Tsai, Fang‐Rong Chang, Wei‐Chao, Lin*, 2020. “Ensemble feature selection in medical datasets: Combining filter, wrapper, and embedded feature selection results.” Expert Syst., e12553. (Impact factor = 2.812. Ranked Q2, Top 34% in COMPUTER SCIENCE, THEORY & METHODS - SCIE).
- Yun-Chien Lai, Chi-Jung Tai1, Mohamed El-Shazly, Yu-Che Chuang, Shu-Tuan Chiang, Yi-Hong Tsai, Dezső Csupor, Judith Hohmann, Yang-Chang Wu*, Fang-Rong Chang*, 2019. “Quantification and simplified detoxification investigation on Fuzi, root of Aconitum carmichaelii.” Nat. Prod. Commun., 14(10), 1-8.
- Yu-Ting Tseng, Yi-Hong Tsai¸ Ferenc Fülöp, Fang‐Rong Chang, and Yi-Ching Lo*, 2019. “2-Iodo-4’-methoxychalcone attenuates methylglyoxal-induced neurotoxicity by activation of GLP-1 receptor and enhancement of neurotrophic signal, antioxidant defense and glyoxalase pathway.” Molecules, 24(12), 2249.
- Hung Su, Kuan-Ting Liu, Bai-Hsiun Chen, Yen-Ping Lin, Yu-Min Jiang, Yi-Hong Tsai¸ Fang-Rong Chang, Jentaie Shiea*, Chi-Wei Lee*, 2019. “Rapid identification of herbal toxins using electrospray laser desorption ionization mass spectrometry for emergency care.” J. Food Drug Anal., 27, 2, 415−427.
- Chi-Ying Li, I-Wen Lo, Yen-Ping Hsueh, Yu-Ming Chung, Shih-Wei Wang, Michal Korinek, Yi-Hong Tsai¸ Yuan-Bin Cheng, Tsong-Long Hwang, Clay C. C. Wang, Fang-Rong Chang, Yang-Chang Wu, 2019. “Epigenetic manipulation induces the production of coumarin-type secondary metabolite from Arthrobotrys foliicola.” Isr. J. Chem., 59(5), 432-438.
- Chi-Ting Hsieh, Fang-Rong Chang, Yi-Hong Tsai, Yang-Chang Wu and Tusty-Jiuan Hsieh*, 2018. “2-Bromo-4’-methoxychalcone and 2-iodo-4’-methoxychalcone prevent progression of hyperglycemia and obesity via 5’-adenosine-monophosphate-activated protein kinase in diet-induced obese mice.” Int. J. Mol. Sci., 19(9), 2763.
- Yi-Hong Tsai1, Chien-Kei Wei1, Michal Korinek, Pei-Hsuan Hung, Mohamed El-Shazly, Yuan-Bin Cheng, Yang-Chang Wu, Tusty-Jiuan Hsieh*, and Fang-Rong Chang*, 2017. “6-Paradol and 6-shogaol, the pungent compounds of ginger, promote glucose utilization in adipocytes and myotubes, and 6-paradol reduces blood glucose in high-fat diet mice.” Int. J. Mol. Sci., 18(1), 168. First author.
- Michal Korinek, Yi-Hong Tsai, Mohamed El-Shazly, Kuei-Hung Lai, Anders Backlund, Shou-Fang Wu, Wan-Chun Lai, Tung-Ying Wu, Shu-Li Chen, Yang-Chang Wu, Yuan-Bin Cheng, Tsong-Long Hwang*, Bing-Hung Chen*, and Fang-Rong Chang*, 2017. “Anti-allergic hydroxy fatty acids from Typhonium blumei explored through ChemGPS-NP.” Front. Pharmacol., 8, 356.
- Santhaseelan Henciya, Prabha Seturaman, Arthur Rathinam James, Yi-Hong Tsai, Rahul Nikam, Yang-Chang Wu, Hans-Uwe Dahms, Fang-Rong Chang*, 2017. “Biopharmaceutical potentials of Prosopis spp. (Mimosaceae, Leguminosa).” J. Food Drug Anal., 25(1), 187−196.
- Santhaseelan Henciya, Prabha Seturaman, Arthur Rathinam James, Yi-Hong Tsai, Rahul Nikam, Yang-Chang Wu, Hans-Uwe Dahms, Fang-Rong Chang*, 2017. “Corrigendum to “Biopharmaceutical potentials of Prosopis spp. (Mimosaceae, Leguminosa)” (Journal of Food and Drug Analysis (2017) 25(1) (S1021949816301697) (10.1016/j.jfda.2016.11.001))” J. Food Drug Anal., 25(3), 748−749.
- Yi-Hong Tsai1, Yuan-Bin Cheng1, I-Wen Lo, Chen-Chang Haung, Yu-Chi Tsai, Ludger Beerhues, Mohamed El-Shazly, Ming-Feng Hou, Shyng-Shiou Yuan, Chin-Chung Wu, Fang-Rong Chang*, and Yang-Chang Wu*, 2015. “Pandalisines A and B, novel indolizidine alkaloids from the leaves of Pandanus utilis.” Bioorg. Med. Chem. Lett., 25, 4333–4336. First author.
- Tung-Ying Wu, Ying-Chi Du, Yu-Ming Hsu, Chi-Yu Lu, Abdel Nasser B. Singab, Mohamed El-Shazly, Tsong-Long Hwang, Wan-Yu Lin, Kuei-Hung Lai, Mei-Chin Lu, Yi-Hong Tsai, Ming-Feng Hou, Tsai-Hui Du*, and Fang-Rong Chang*, 2013. “New approach to the characterization and quantification of Antrodia cinnamomea benzenoid components utilizing HPLC-PDA, qNMR and HPLC-tandem MS: Comparing the wild fruiting bodies and its artificial cultivated commercial products.” Food Res. Int., 51, 23−31.
- Chia-Lin Lee, Tsong-Long Hwang, Wan-Jung He, Yi-Hong Tsai, Chiao-Ting Yen, Hsin-Fu Yen, Chao-Jung Chen, Wei-Yi Chang, Yang-Chang Wu, 2013. “Anti-neutrophilic inflammatory steroidal glycosides from Solanum torvum.” Phytochemistry, 95, 315-321.
- Yi-Hong Tsai1, Tusty-Jiuan Hsieh, Min-Chun Liao, Ying-Chi Du, Pei-Jung Lien, Chuan-Chia Sun, Fang-Rong Chang*, and Yang-Chang Wu*, 2012. “Anti-diabetic properties of non-polar Toona sinensis Roem. extract prepared by supercritical-CO2 fluid.” Food Chem. Toxicol., 50, 779−789. First author.
- Chi-Ting Hsieh, Tusty-Jiuan Hsieh, Mohamed El-Shazly, Da-Wei Chuang, Yi-Hong Tsai, Chiao-Ting Yen, Shou-Fang Wu, Yang-Chang Wu*, and Fang-Rong Chang*, 2012. “Synthesis of Chalcone Derivatives as Potential Anti-diabetic Agents.” Bioorg. Med. Chem. Lett., 22, 3912−3915.
- Balaji D. Barve, Yang-Chang Wu, Mohamed El-Shazly, Da-Wei Chuang, Yu-Ming Chung, Yi-Hong Tsai, Shou-Fang Wu, Michal Korinek, Ying-Chi Du, Chi-Ting Hsieh, Jeh-Jeng Wang*, and Fang-Rong Chang*, 2012. “Synthesis of carbamates by direct C–H bond activation of formamides.” Eur. J. Org. Chem., 34, 6760−6766.
- Tusty-Jiuan Hsieh, Pei-Chen Hsieh, Yi-Hong Tsai, Chia-Fang Wu, Chia-Chu Liu, Ming-Yen Lin, Ming-Tsang Wu*, 2012. “Melamine induces human renal proximal tubular cell injury via transforming growth factor-β and oxidative stress.” Toxicol. Sci., 130(1), 17-32.
- I-Min Liu, Wen-Jen Yu, Shorong-Shii Liou, Thing-Fong Tzeng, Yi-Hong Tsai, Juei-Tang Cheng*, 2007. “Role of alcohol in the induction of hepatic injury by chronic consumption of medicated wine.” J. Food Drug Anal., 15, 4, Article 4.
Granted and filing Patents
- Invention, Title: Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic disease, the preparation method and the use thereof, Country: USA, Patent No.: US10668122B2
- Invention, Title: Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof, Country: TW, Patent No.: I492755
- Invention, Title: Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof, Country: CN, Patent No.: CN102821771B
- Invention, Title: Composition for treating diabetes and metabolic diseases and a preparation method thereof, Country: USA, Patent No.: US9085520B2
- Invention, Title: Composition for treating diabetes and metabolic diseases and a preparation method thereof, Country: TW, Patent No.: I417088
- Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: USA, Patent No.: US 11,771,729 B2
- Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: JP, Patent No.: JP7446003B2
- Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: CN, Patent No.: CN115477604B
- Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: TW, Publication No.: 202300165
- Invention, Title: Hibiscus sabdariffa seed extract for anti-oxidation, anti-inflammation, anti-UVB damage, anti-allergy, whitening, moisturizing and anti-wrinkle formation, Country: TW, Publication No.: 202337482
- Invention, Title: Hibiscus sabdariffa seed extract for anti-oxidation, anti-inflammation, anti-UVB damage, anti-allergy, whitening, moisturizing and anti-wrinkle formation, Country: CN, Publication No.: CN116019744A
- Invention, Title: Hibiscus sabdariffa seed extract for anti-oxidation, anti-inflammation, anti-UVB damage, anti-allergy, whitening, moisturizing and anti-wrinkle formation, Country: USA, Status: Filing
- Invention, Title: Use of Caulerpa lentillifera extract for making a composition promoting anti-inflammation, anti-oxidation and anti-cancer of skin, Country: TW, Patent No.: I790760
- Invention, Title: Use of Caulerpa lentillifera composition for promoting anti-inflammation, anti-oxidation, slowing down collagen degradation and anti-cancer of skin, Country: TW, Patent No.: I837515
- Invention, Title: Houttuynia cordata hydroponic culture medium, system and extract of Houttuynia cordata produced by the same and its preparation, Country: TW, Patent No.: I838761
- Utility Model, Title: Device for extracting branches and leaves of Ficus pumila var. awkeotsang, Country: TW, Patent No.: M643653
Technology transfers
- Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method, and the use thereof. Taiwan patent: I492755. Patent Holder: Kaohsiung medical university. Current Assignee: We-Yu Applied Bio-tech Co., Ltd. Royalty: 300,000 NTD.
- Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method, and the use thereof. China patent: I492755. Patent Holder: Kaohsiung medical university. Current Assignee: We-Yu Applied Bio-tech Co., Ltd. Royalty: 1,200,000 NTD.
- Composition for treating diabetes and metabolic diseases and a preparation method thereof. Taiwan patent: I417088; USA patent: US9085520B2. Patent Holder: Kaohsiung medical university. Current Assignee: Oneness Biotech Co., Ltd. Royalty: 30,000,000 NTD (in millstones).
- Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof. US patant: US 11,771,729 B2. Filing patants: Taiwan, Japan, and China patents. Patent Holder: Kaohsiung medical university. Current Assignee: Root & Stem Future biotechnology Co., Ltd. Royalty: 2,000,000 NTD.
- Zink your heart drink. Patent Holder: Kaohsiung medical university. Current Assignee: Joben Bio-Medical Co., Ltd. Royalty: 1,000,000 NTD.
- Vitality up Antrodia cinnamomea Drink. Patent Holder: Kaohsiung medical university. Current Assignee: Joben Bio-Medical Co., Ltd. Royalty: 1,000,000 NTD.
- Energy and Beauty Soy Protein Isolate. Vitality up Antrodia cinnamomea Drink. Patent Holder: Kaohsiung medical university. Current Assignee: Joben Bio-Medical Co., Ltd. Royalty: 1,000,000 NTD.